
Europe Dialysis Equipment Market
No. of Pages: 150 | Report Code: BMIPUB00031646 | Category: Life Sciences
No. of Pages: 150 | Report Code: BMIPUB00031646 | Category: Life Sciences
The Europe dialysis equipment market size is expected to reach US$ 5,568.50 million by 2031 from US$ 3,798.80 million in 2024. The market is estimated to record a CAGR of 5.62% from 2025 to 2031.
The dialysis equipment market in Europe is experiencing significant growth driven by growing burden of kidney disease. According to the European Renal Association, over 546,000 individuals were receiving renal replacement therapy (RRT) for ESRD, with significant variations across countries.
The incidence of dialysis varies widely, with countries such as Portugal reporting some of the highest prevalence rates, while others, such as Ukraine, have significantly lower numbers. The increasing burden of CKD is largely driven by aging populations, diabetes, and hypertension, which are major risk factors for kidney disease. Additionally, disparities in access to kidney replacement therapy (KRT) have led to variations in treatment availability across different regions in Europe.
Europe Dialysis Equipment Market Segmentation Analysis:
Key segments that contributed to the derivation of the dialysis equipment market analysis are product, application, and end user.
The Europe dialysis equipment market is segmented into Belgium, Netherlands, Luxembourg, Germany, France, Italy, Russian Federation, Spain, Switzerland, Turkiye, Poland, Sweden, Austria, Switzerland, United Kingdom, Denmark, Ukraine, Romania, Greece, Portugal, Norway, and Finland. The European dialysis equipment market is a sizeable and matured segment of the healthcare industry globally, and projected to continue to see growth at a steady pace. Growth is expected to continue for the European dialysis equipment market for two significant reasons. First, the growing prevalence of Chronic Kidney Disease (CKD) and end-stage renal disease (ESRD), many of whom are older populations with a high incidence of diabetes and hypertension. Secondly, the established universal healthcare systems in Europe give dialysis a large share of the healthcare market, while the significant focus on improving the quality of life of patients and patient care costs has initiated an intentional pivot towards home-based dialysis solutions. The same major, international companies are driving innovation in the market, especially in Europe many of which with established and growing markets operating in them (i.e. Fresenius Medical Care headquartered in Germany). As several examples in 2024, Fresenius Medical Care introduced a program that expanded home hemodialysis across Germany and the U.K. (March 2025, 2024 trends), and a. Braun Avitum launched their Dialog iQ next-gen hemodialysis machine in Italy and Spain (February 2025, 2024 trends).
Based on region, the Europe dialysis equipment market is further segmented into the Belgium, Netherlands, Luxembourg, Germany, France, Italy, Russian Federation, Spain, Switzerland, Turkiye, Poland, Sweden, Austria, Switzerland, United Kingdom, Denmark, Ukraine, Romania, Greece, Portugal, Norway, and Finland. The Germany held the largest share in 2024.
The dialysis equipment marketplace in Germany is strongly influenced by the country's demographic trends as well as a high prevalence of chronic illnesses leading to kidney failure. The population is ageing rapidly, with higher than average proportion over the age of 65 and a this is not expected to reverse in the next ten years and with a median age of over 45 years projected for 2025, according to Statistics Germany and Worldometer 2024, 2025. This means there will be a larger pool of individuals that are influenced by chronic kidney disease (compounding other major chronic illnesses such as diabetes and hypertension.) The German Health Report Diabetes 2025 (published November 2024) estimated that over 9 million people in Germany alone are affected by Type 2 diabetes (including undiagnosed), alongside a significant number of Type I, and contributes to many the prevalence of noted non-communicable diseases - diabetes and hypertension are both leading contributors to CKD that subsequently progresses to ESRD. In September 2024 the German Society of Nephrology (DGfN) estimated in excess of 9 million in Germany are affected by CKD, and -100,000 patients in need of permanent dialysis. The Versorgungsatlas report from October 2024 refers to a notice increase in DKP prevalence diagnosed in patients aged over 40. The vast number of RRT required creates an ongoing need for dialysis equipment such as hemodialysis machines, dialyzers, and associated consumables, predominantly sourced from dialysis centres and hospitals, with some also from patients using home-based therapies. The ongoing management of this large patient population necessitates continuous investment in and provision of dialysis technology across the German healthcare system. Italy is characterized by one of the oldest populations in Europe; by December 31, 2023, the median age reached 46.6 years, with individuals over 65 constituting 24.3% of the population, an increase from 24% in 2022, according to ISTAT data released in December 2024. This aging trend is a major contributor to the burden of CKD. Diabetes and hypertension are also widespread health issues. The need for renal replacement therapy (RRT) is therefore substantial.
Europe Dialysis Equipment Market Company Profiles
Fresenius Medical Care AG & Co KGaA; Baxter International Inc.; B. Braun SE; Nipro Corp; Medtronic Plc, Nikkiso Co Ltd, Teleflex Inc, Asahi Kasei Medical Co., Ltd., Terumo Corp, and DaVita Inc. are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The Europe Dialysis Equipment Market is valued at US$ 3,798.80 Million in 2024, it is projected to reach US$ 5,568.50 Million by 2031.
As per our report Europe Dialysis Equipment Market, the market size is valued at US$ 3,798.80 Million in 2024, projecting it to reach US$ 5,568.50 Million by 2031. This translates to a CAGR of approximately 5.62% during the forecast period.
The Europe Dialysis Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Dialysis Equipment Market report:
The Europe Dialysis Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Dialysis Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Dialysis Equipment Market value chain can benefit from the information contained in a comprehensive market report.